Four‐year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi‐centre study

IMPORTANCE: The transscleral XEN Glaucoma Gel Microstent (XEN‐GGM, Allergan Plc., Parsippany, New Jersey) is implanted by a minimally invasive ab interno technique. BACKGROUND: The present study aims to assess the long‐term clinical outcomes in patients after XEN‐GGM implantation. DESIGN: This prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenzhofer, Markus, Kersten‐Gomez, Inga, Sheybani, Arsham, Gulamhusein, Husayn, Strohmaier, Clemens, Hohensinn, Melchior, Burkhard Dick, H, Hitzl, Wolfgang, Eisenkopf, Lisa, Sedarous, Fady, Ahmed, Iqbal I., Reitsamer, Herbert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767491/
https://www.ncbi.nlm.nih.gov/pubmed/30578661
http://dx.doi.org/10.1111/ceo.13463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767491/
https://www.ncbi.nlm.nih.gov/pubmed/30578661
http://dx.doi.org/10.1111/ceo.13463

Ejemplares similares